NEW YORK, Dec. 5 - Nearly 70 researchers based at the University of North Carolina at Capel HIl over the next four years will be getting microarray technology thanks to a $2.5 million grant from the NIH.
The scientists, exclusively those who currently receive funding from the NIH's National Heart, Lung and Blood Institute, will use the arrays in cardiopulmonary research, the school said in a statement released on Tuesday.
The work will be part of a newly created center, the Carolina Cardiopulmonary Gene Expression Services, which "represents a major expansion of gene expression, microarray and bioinformatics services" for NHLBI-funded scientists on campus.
According to UNC, at least 67 of its investigators are funded by the NHLBI to study cardiopulmonary disorders. "However, the rapid revolution of gene-expression technologies has precluded [them] from taking advantage of these applications in ongoing funded projects," the statement read.
Though it was not immediately known what kinds of technologies will likely attract UNC's cash, the school hinted that its researchers would get access to microarray services "as diverse as experimental design" and sample prep- and data-interpretation tools that use "advanced bioinformatics approaches."
"Over the next four years, my goal ... is to put UNC at the forefront of microarray and gene-expression analysis for diseases of the heart, lungs, and blood," said Cam Patterson, director of the Carolina Cardiovascular Biology Center and PI for the NIH grant.